Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | RORC | P51449 | 1/20 | 0.36 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.35 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | CCR5 | P51681 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4026679 | 0.88 | L3MBTL1 (0.34) | L3MBTL1RORCSLC6A1KMT2AMAPK1 | |
| SCHEMBL4024600 | 0.88 | L3MBTL1 (0.34) | L3MBTL1RORCSLC6A1KMT2AMAPK1 | |
| SCHEMBL4028142 | 0.84 | RORC (0.39) | RORCSLC18A3KMT2AMEN1ALDH1A1 | |
| SCHEMBL4020295 | 0.84 | PDE10A (0.36) | L3MBTL1RORCSLC6A1ALDH1A1 | |
| SCHEMBL4026859 | 0.82 | HTR1A (0.36) | L3MBTL1RORCKMT2AMEN1KCNH2 | |
| SCHEMBL4027189 | 0.81 | KCNH2 (0.35) | RORCSLC6A1KMT2AKCNH2ALDH1A1 | |
| SCHEMBL4020571 | 0.81 | KCNH2 (0.35) | RORCSLC6A1KMT2AKCNH2ALDH1A1 | |
| SCHEMBL4028852 | 0.81 | KCNH2 (0.37) | RORCKMT2AKCNH2ALDH1A1HTR2A | |
| SCHEMBL4022920 | 0.80 | RORC (0.40) | RORCSLC18A3KMT2ASLC6A2SLC6A3 | |
| SCHEMBL4021193 | 0.79 | ALDH1A1 (0.37) | RORCKMT2AMAPK1MEN1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7572814-B2 | 3,5-dibenzoyl-4-phenyl-piperidine anti-cancer compounds | CYTOKINETICS, INCORPORATED (US) | 2009-08-11 | — | — | US | disclosed |
| US-20070161674-A1 | Certain chemical entities, compositions, and methods | CYTOKINETICS, INC. | 2007-07-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070161674-A1 | Certain chemical entities, compositions, and methods | TP53, VHL, RB1 | L3MBTL1 3696/4885RORC 183/4885SLC18A3 2628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.